Ketamine & Esketamine at 39th ECNP Congress
1 session on ketamine & esketamine · October 10–13, 2026, Munich, Germany. Compare ketamine & esketamine at other meetings →
Tuesday, October 13
Symposium
S19 – Bridging preclinical and clinical findings in psychedelic research – translational advances in psychedelic research
Tomas Palenicek · Luisa Pinto · Sophie Holmes · Annette Johansen
Psilocybin and ketamine effects on neurogenesis, synaptic plasticity, and the role of setting, from bench to PET imaging.
Other topics at this meeting
Neuroscience & Mechanisms 23Drug Pipeline & Clinical Trials 8Digital Psychiatry & AI 7Pharmacogenomics & Precision Psychiatry 7Inflammation & Immunopsychiatry 6Schizophrenia & Psychosis 6Child & Adolescent 5Depression 5Autism & Neurodevelopmental Disorders 4Neuromodulation (ECT, TMS) 4OCD & Related Disorders 4ADHD 3